Science Explorer Interactive view Map
Company · San Diego · United States

Mabvax Therapeutics (United States)

Research works
24
▼ 2% vs 2013–17
Citations
240
10.1 per fractional work
Top-10% rate
4.3%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Mabvax Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.83× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.59× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.31× its world share, 0 worksImmunology and Micro…Neuroscience: 4.41× its world share, 1 worksNeuroscienceChemistry: 1.32× its world share, 0 worksChemistryComputer Science: 0.53× its world share, 0 worksComputer ScienceMedicine: 3.63× its world share, 6 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Neuroscience, 4.4×. Every wedge is a field page.

Which keywords describe research at Mabvax Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Immunotherapy, Chemotherapy, Cancer, PET Imaging, Targeted Therapy, Fc Receptors and Therapeutic Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Glycosylation4▲ 79×2 topics
  2. Immunotherapy3▲ 19×6 topics
  3. Chemotherapy3▲ 16×4 topics
  4. Cancer3▲ 7.7×5 topics
  5. PET Imaging2▲ 47×3 topics
  6. Targeted Therapy2▲ 46×4 topics
  7. Fc Receptors2▲ 94×1 topic
  8. Therapeutic Antibodies2▲ 73×1 topic
  9. Tumor Targeting2▲ 62×3 topics
  10. Breast Cancer2▲ 28×2 topics
  11. Glycans2▲ 98×1 topic
  12. Immune System2▲ 25×1 topic
  13. Cancer Treatment2▲ 29×2 topics
  14. HER22▲ 252×1 topic
  15. Radioimmunotherapy2▲ 187×1 topic
  16. Radiopharmaceuticals2▲ 187×1 topic
  17. Trastuzumab2▲ 179×1 topic
  18. Gene Therapy2▲ 27×2 topics
  19. Tumor Regression2▲ 78×2 topics
  20. Arginine Deprivation2▲ 145×1 topic
  21. Bacterial Therapy2▲ 145×1 topic
  22. Epidemiology2▲ 1.56×6 topics
  23. Tumor Microenvironment1▲ 16×4 topics
  24. Neuroinflammation1▲ 19×3 topics
  25. Oxidative Stress1▲ 2.8×4 topics
  26. Inflammation1▲ 2.0×5 topics
  27. Neurodegeneration1▲ 15×2 topics
  28. Genetic Mutations1▲ 8.2×2 topics

Which research topics does Mabvax Therapeutics (United States) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Alzheimer's disease research and treatments and Neuroinflammation and Neurodegeneration Mechanisms.

  1. 1 HER2/EGFR in Cancer Research Oncology 2 works
  2. 2 Cancer Treatment and Pharmacology Oncology 0 works
  3. 3 Alzheimer's disease research and treatments Physiology 0 works
  4. 4 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Colorectal Cancer Treatments and Studies Oncology 0 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.2%not open69.8%

World: 28% of research is openly available.

with international co-authors9.0%domestic only91.0%

World: 19% is written across borders.

How has Mabvax Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 2% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.